DD240016A5 - Verfahren zur herstellung von 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeuren - Google Patents

Verfahren zur herstellung von 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeuren Download PDF

Info

Publication number
DD240016A5
DD240016A5 DD85276974A DD27697485A DD240016A5 DD 240016 A5 DD240016 A5 DD 240016A5 DD 85276974 A DD85276974 A DD 85276974A DD 27697485 A DD27697485 A DD 27697485A DD 240016 A5 DD240016 A5 DD 240016A5
Authority
DD
German Democratic Republic
Prior art keywords
oxo
cyclopropyl
piperazinyl
dihydro
formula
Prior art date
Application number
DD85276974A
Other languages
German (de)
English (en)
Inventor
Uwe Petersen
Klaus Grohe
Hans-Joachim Zeiler
Karl G Metzger
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD240016A5 publication Critical patent/DD240016A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD85276974A 1984-06-04 1985-06-03 Verfahren zur herstellung von 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeuren DD240016A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843420798 DE3420798A1 (de) 1984-06-04 1984-06-04 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren

Publications (1)

Publication Number Publication Date
DD240016A5 true DD240016A5 (de) 1986-10-15

Family

ID=6237597

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85276974A DD240016A5 (de) 1984-06-04 1985-06-03 Verfahren zur herstellung von 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeuren

Country Status (21)

Country Link
US (1) US4599334A (es)
EP (1) EP0169993B1 (es)
JP (2) JPS611683A (es)
KR (1) KR920000759B1 (es)
AT (1) ATE39488T1 (es)
AU (1) AU571333B2 (es)
CA (1) CA1248954A (es)
DD (1) DD240016A5 (es)
DE (2) DE3420798A1 (es)
DK (1) DK162527C (es)
ES (3) ES8607294A1 (es)
FI (1) FI82041C (es)
GR (1) GR851314B (es)
HU (1) HU194866B (es)
IE (1) IE57814B1 (es)
IL (1) IL75370A (es)
NO (1) NO165105C (es)
NZ (1) NZ212271A (es)
PH (1) PH22492A (es)
PT (1) PT80580B (es)
ZA (1) ZA854168B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468861A (en) * 1984-06-04 1995-11-21 Bayer Aktiengesellschaft 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and alkyl esters thereof
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS6259263A (ja) * 1985-09-10 1987-03-14 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
JPH0637489B2 (ja) * 1985-09-21 1994-05-18 杏林製薬株式会社 キノロンカルボン酸誘導体およびその製造方法
NZ217650A (en) * 1985-09-24 1989-09-27 Hoffmann La Roche Quinoline derivatives and pharmaceutical compositions
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3542002A1 (de) * 1985-11-28 1987-06-04 Bayer Ag 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
EP0230053A3 (en) * 1986-01-17 1988-03-30 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
HU204512B (en) * 1986-01-20 1992-01-28 Kyorin Seiyaku Kk New process for producing quinoline-carboxylic acid derivatives
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
US4689423A (en) * 1986-04-01 1987-08-25 Warner-Lambert Company Process for the preparation of 2,3,4,5-tetrafluorobenzoyl acetates
HU196987B (en) * 1986-10-15 1989-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing quinoline-carboxylic acid derivatives
DE3639465A1 (de) * 1986-11-18 1988-05-19 Hoechst Ag Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
IL90635A0 (en) * 1988-07-15 1990-01-18 Abbott Lab Process for the preparation of quinoline antibacterial compounds
FR2653663A1 (en) * 1989-10-30 1991-05-03 Bellon Labor Sa Roger Novel benzo[1,8]naphthyridine derivatives, their preparation and compositions containing them
RO108347B1 (ro) * 1989-10-30 1994-04-28 Bellon Labor Sa Roger DERIVATI DE BENZO-(b)-NAFTIRIDIN-1,8 SI PROCEDEU DE PREPARARE A ACESTORA
FR2664595B1 (fr) * 1990-07-10 1992-09-18 Bellon Labor Sa Roger Nouveaux derives de benzonaphtyridine-1,8, leur preparation et les compositions qui les contiennent.
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
EP0525057B1 (en) 1990-04-18 2000-06-14 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolonyl lactams
DE10108750A1 (de) * 2001-02-23 2002-09-05 Bayer Ag Verbessertes Verfahren zur Herstellung von Fluorchinoloncarbonsäuren
KR100519158B1 (ko) * 2002-12-21 2005-10-06 주식회사유한양행 퀴놀론 카르복실레이트 유도체의 제조방법
JP2009531418A (ja) * 2006-03-28 2009-09-03 ザ プロクター アンド ギャンブル カンパニー キノロン中間体調製のためのカップリング方法
WO2007110834A2 (en) * 2006-03-28 2007-10-04 The Procter & Gamble Company Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
CA3098060A1 (en) 2018-04-25 2019-10-31 Bayer Animal Health Gmbh Process for the hydrolysis of quinolone carboxylic esters

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
SE440354B (sv) * 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
DE3142856A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 2,4-dichlor-5-fluor-benzoylchlorid
JPS5910580A (ja) * 1982-07-09 1984-01-20 Hokuriku Seiyaku Co Ltd ７−フエニル置換ピペラジノ−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸誘導体
JPS5929685A (ja) * 1982-08-11 1984-02-16 Hokuriku Seiyaku Co Ltd ７−置換フエニルピペラジノ−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸誘導体
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306772A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Also Published As

Publication number Publication date
EP0169993A3 (en) 1986-03-26
AU4320685A (en) 1985-12-12
PT80580A (en) 1985-07-01
IE851364L (en) 1985-12-04
GR851314B (es) 1985-11-25
ES543839A0 (es) 1986-06-01
ES552573A0 (es) 1987-11-01
JPS611683A (ja) 1986-01-07
NO165105C (no) 1990-12-27
ES8800195A1 (es) 1987-11-01
FI852205A0 (fi) 1985-05-31
DE3567021D1 (en) 1989-02-02
AU571333B2 (en) 1988-04-14
EP0169993A2 (de) 1986-02-05
ATE39488T1 (de) 1989-01-15
DK162527C (da) 1992-03-30
HUT39175A (en) 1986-08-28
NZ212271A (en) 1988-10-28
NO852063L (no) 1985-12-05
JPH06279411A (ja) 1994-10-04
DK249685A (da) 1985-12-05
PH22492A (en) 1988-09-12
PT80580B (pt) 1987-11-11
CA1259315C (es) 1989-09-12
KR920000759B1 (ko) 1992-01-21
ES8800196A1 (es) 1987-11-01
DK162527B (da) 1991-11-11
HU194866B (en) 1988-03-28
IE57814B1 (en) 1993-04-21
FI852205L (fi) 1985-12-05
EP0169993B1 (de) 1988-12-28
DE3420798A1 (de) 1985-12-05
IL75370A (en) 1989-03-31
FI82041B (fi) 1990-09-28
DK249685D0 (da) 1985-06-03
FI82041C (fi) 1991-01-10
CA1248954A (en) 1989-01-17
NO165105B (no) 1990-09-17
ES552574A0 (es) 1987-11-01
US4599334A (en) 1986-07-08
ZA854168B (en) 1986-01-29
KR860000280A (ko) 1986-01-27
IL75370A0 (en) 1985-09-29
ES8607294A1 (es) 1986-06-01

Similar Documents

Publication Publication Date Title
EP0126355B1 (de) 7-Amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0169993B1 (de) 7-(3-Aryl-1-piperazinyl)-sowie 7-(3-Cyclohexyl-1-piperazinyl)-3-chinoloncarbonsäuren
EP0167763B1 (de) 7-Amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zur ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0198192B1 (de) 7-Amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0113093B1 (de) 1-Cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(alkyl-1-piperazinyl)-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0164619B1 (de) 2,4,5-Trihalogen- bzw. 2,3,4,5-Tetrahalogenbenzolderivate und Verfahren zu ihrer Herstellung
EP0155587B1 (de) 1,7-Diamino-1,4-dihydro-4-oxo-3-(aza) chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie ihre Verwendung bei der Bekämpfung bakterieller Erkrankungen
EP0276700A1 (de) 8-Cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende antibakterielle Mittel
DE3522406A1 (de) Verfahren zur herstellung von 1,8-verbrueckten 4-chinolon-3-carbonsaeuren
EP0187376B1 (de) 6,7-Disubstituierte 1-Cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carbonsäuren
EP0113092B1 (de) 1-Cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(4-(oxoalkyl)-1-piperazinyl)-3-chinolincarbonsäuren und ihre Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0201829A1 (de) 1-Aryl-4-chinolon-3-carbonsäuren
EP0166939B1 (de) 1-Cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(3-oxo-1-piperazinyl)-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
EP0191390B1 (de) 1-Cyclopropyl-1,4-dihydro-4-oxo-7-[4-(2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl]-3-chinolincarbonsäuren, Verfahren zu ihrer Herstellung sowie diese enthaltende antibakterielle Mittel
DE3542002A1 (de) 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3543513A1 (de) Enantiomerenreine 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DD241258A5 (de) Verfahren zur herstellung 6,7-disubstituierter 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carbonsaeuren

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee